Alcohol related cirrhosis already takes years of healthy life from people across Europe and the United States. The trend is heading the wrong way. New research presented at UEG Week 2026 in Barcelona delivers a stark warning. By 2050, the disability burden is set to climb steeply in the US, Central Europe and Eastern Europe. That includes the heart failure that can accompany the disease.
Alcohol Related Cirrhosis Disability Has Risen in Every Region
Elena Alupei of the Carol Davila University of Medicine and Pharmacy in Bucharest led the team. They analysed Global Burden of Disease 2023 data from Central, Eastern and Western Europe and the US between 1990 and 2023. Years lived with disability, known as YLD, was the yardstick. It captures time spent living with ill health. The researchers then modelled how the burden could shift through to 2050.
The picture since 1990 is clear. Medical Xpress, which covered the findings, reports that the burden from alcohol related cirrhosis complicated by heart failure has grown considerably in all four regions. Western Europe recorded the highest rate throughout, and its rate climbed by 28.6%. The steepest rises came elsewhere. Central Europe jumped by 82.9% and Eastern Europe by 74.7%, while the US recorded a 38.5% increase.
Older Adults and Men Carry the Heaviest Load
Age makes a dramatic difference. In all four regions, people aged 70 and older had YLD rates 10 to 16 times higher than those aged 15 to 49. Sex matters too. Men bore a greater burden than women everywhere. Male to female ratios ran from 1.86 in Eastern Europe to 3.27 in Central Europe.
Study author Dr Ashesh Das said the pattern is “far from uniform”. He argued that the marked gaps between regions matter. A single, standard approach to prevention and health care planning is unlikely to be enough. Alupei added her own caution at the congress. The narrowing gap between regions, she said, reflects smaller relative differences and not a fall in disability.
Projections Point to a Steep Climb by 2050
Looking ahead, the modelling is sobering. Compared with 2023, the YLD burden linked to alcohol related cirrhosis could rise by 65.4% in the US by 2050. Central Europe faces 49.6% and Eastern Europe 66.6%. Western Europe stands apart, with a projected decline of 19.0%.
Older Americans face a particularly sharp increase. The YLD rate among those aged 70 and older is predicted to reach 1.893 per 100,000 by 2050, which is 73.7% higher than in 2023.
These forecasts still need careful reading. As medwireNews reported, Alupei described the projections as exploratory, and she said they cannot establish what drives the differences between regions. Higher rates might reflect more diagnoses, longer illness, better survival despite lasting disability, or more severe disease. The YLD data alone cannot separate those explanations.
Why Prevention Must Lead the Response to Cirrhosis Caused by Alcohol
The wider context is grim. Notably, the WHO European Region has the highest level of alcohol consumption globally. Alcohol is causally linked to more than 200 diseases and health conditions, including liver cirrhosis and cardiovascular disease. In Europe, it is also the most common cause of death from liver disease.
The researchers stress the need to reduce alcohol related harm. They point to WHO measures such as alcohol taxation and restrictions on availability and marketing. Their conclusion, again via medwireNews, is that Central and Eastern Europe and the US need urgent strategies to cut alcohol use, particularly for ageing populations. The heavy male predominance, they add, calls for sex specific interventions.
Das warned that without effective prevention and planning, the burden could keep growing in several regions. Health systems must also brace for the combined strain on hepatology, cardiology and wider care services. Western Europe’s projected fall may offer a roadmap. Das said researchers first need to understand what is driving the difference, and whether the lessons travel.
Every case of cirrhosis caused by alcohol starts with alcohol. Stopping that harm before it reaches the liver and the heart spares people the disability altogether. These projections show how much is at stake.
(Source: WRD News)